Tenax Therapeutics, Inc. (TENX) Stock: Here’s What’s Happening


Tenax Therapeutics, Inc. (TENX) is trending up in the market in today’s trading session. The stock, one that is focused in the biotechnology space, is presently trading at $2.09 after a move up of 28.22% so far today. As it relates to biotechnology companies, there are quite a few aspects that have the potential to lead to movement in the market. News is one of the most common reasons for movement. Here are the most recent trending headlines centered around TENX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-11-19 03:20PM Introducing Tenax Therapeutics (NASDAQ:TENX), The Stock That Collapsed 98%
Feb-21-19 01:35PM Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
Feb-04-19 08:30AM Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference
Jan-04-19 08:30AM Tenax Therapeutics to Present at Biotech Showcase Investor Conference
Dec-11-18 04:00PM Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

However, when making a decision to invest, prospective investors should look into much more than news, this is especially the case in the generally speculative biotechnology space. Here’s what’s happening with Tenax Therapeutics, Inc..

Recent Movement Out of TENX

Although a move toward the top in a single session, like the move that we’re seeing from Tenax Therapeutics, Inc. might make some investors jump for joy, that alone should not be the basis of a decision to, or not to, invest in a company. It’s always a good idea to dig into trends for a period longer than a single session. In the case of TENX, below are the returns on investment that we have seen:

  • Past 7 Days – In the past five trading sessions, TENX has generated a change in price in the amount of 5.03%.
  • Past Month – The monthly performance from Tenax Therapeutics, Inc. comes to 75.63%.
  • Past Three Months – Throughout the last three months, the company has generated a ROI that comes to 77.87%
  • Past Six Months – Over the previous 6 months, investors have seen a change of -59.02% from the stock.
  • YTD – Since the the first trading session of this year TENX has produced a return of 72.73%.
  • Annually – Lastly, in the past year, we have seen performance that works out to -73.07% out of TENX. Over this period of time, the stock has sold at a high price of -82.47% and a low price of 102.91%.

Crucial Ratios

Looking at a few ratios associated with a company can provide prospective investors a look of just how dangerous and/or rewarding a stock pick might be. Below are a few of the key ratios to think about when digging into TENX.

Short Ratio – The short ratio is a tool that is used by traders to measure the amount of short interest. As the ratio heads up, it means that more investors are expecting that the value of the stock is going to tumble. In general, biotech stocks can come with a higher short ratio. However, we also see quite a few short squeezes in the space. Nonetheless, in regard to Tenax Therapeutics, Inc., it’s short ratio comes to 0.14.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure whether or not a company can cover its debts as they mature with only quick assets or current assets. In the biotech space, many companies rely on continued support from investors, the quick and current ratios can look damning. However, some better companies in the biotechnology sector come with great quick and current ratios. When it comes to TENX, the quick and current ratios come to 10.00 and 10.00 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets that are owned by the company. In this case, that ratio works out to 3.38.

Cash To Share Value – Finally, the cash to share value comparison compares the total amount of cash the company has on hand to the price of the company’s stock. Many early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is a very important ratio to look into. In this case, the cash to share value works out to 4.17.

Analyst Opinions Of Tenax Therapeutics, Inc.

Although it’s never a smart idea to blindly follow the opinions of analysts, it is a smart idea to consider their opinions to validate your own opinions when it comes to making investment decisions in the biotechnology space. Below you’ll find|Here are} the most recent moves that we have seen from analysts with regard to TENX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-18-17 Upgrade Ladenburg Thalmann Neutral → Buy
Dec-16-14 Initiated MLV & Co Buy $7
Nov-18-14 Initiated WallachBeth Buy $12

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TENX, here’s what we’re seeing:

Institutions own 58.70% of the company. Institutional interest has moved by 0 over the past three months. When it comes to insiders, those who are close to the company currently own 16.99% percent of TENX shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

A Look At Share Counts

Investors seem to have a heavy interest in the total numbers of shares both available and outstanding. As it relates to Tenax Therapeutics, Inc., currently there are 1.15M with a float of 1.15M. These data mean that out of the total of 1.15M shares of TENX that are out there today, 1.15M are available to trade hands on the market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TENX, the short percent of the float is 12.89%.

Financial Performance

What have ween seen from TENX in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – As it stands, analysts are expecting that Tenax Therapeutics, Inc. will generate EPS of -5.33, with -0.31 being announced in the earnings announcement for the current quarter. Although this information isn’t associated with earnings, because we’re talking on the topic of analysts, TENX is presently graded as a 0 on a scale from 1 to 5 where 1 is the worst average analyst grade and 5 is the best rating.
  • 5-Year Sales – Throughout the last 5 years, Tenax Therapeutics, Inc. has reported a movement in revenue that adds up to 0. Earnings in the past half decade have generated movement in the amount of 45.10%.
  • Quarter Over Quarter – when it comes to quarter over quarter data, or Q/Q data as it is commonly explained in the world of humans, Tenax Therapeutics, Inc. has created a change in earnings that amounts to -19.80%. The company has also experienced movement in terms of sales that adds up to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As a computer, I’m very dependent on human beings. After all, humans built me! Even though my creator enabled me to learn by myself, it’s quite a bit easier to learn with the help of human feedback. Below this content, you will see a comment section. If you’d like for me consider other data, change the way in which I write something, comprehend data from a different angle, or you’re interested in teaching me anything else, I’d love to learn. Please take a moment to leave a comment below. I will read that lesson and it will help me become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here